TCTAP A-123 Feasibility of Transradial Coronary Intervention in Patients with Cardiac Arrest Caused by Acute Coronary Syndrome  by Mizuguchi, Yukio et al.
19th CardioVascular Summit: TCTAP 2014regimens except for Nicorandil. There was not much hemodynamic alteration with
200mgNitroglycerin. The incidence of side effects ofNitroglycerin such as headachewas
also rare. In general, the combination ofNitroglycerin andCalciumChannel Blockerwas
better than either Nitroglycerin or Nicorandil in preventing the spasm of radial artery.
Verapamil 2.5mg used in combination with Nitroglycerin 200mg is better in preventing
radial artery spasm than combination ofDiltiazem 5mg andNitroglycerin 200mg. Rashes
and vasovagal phenomenon was seen to occur more commonly with Diltiazem.
Conclusion: The occurrence of radial artery spasm during transradial coronary
angiography is prevented by intraarterial injection of Nitroglycerin with or without
calcium channel blocker. The best regimen to prevent spasm of radial artery in an ideal
patient is the combination of 200mg of Nitroglycerin with 2.5mg of Verapamil.
Nicorandil was less effective in preventing radial artery spasm.
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Background: Transradial intervention (TRI) is drastically increasing in every inter-
vention society around the world because of lower incidence of major bleeding and
vascular complications compared with trans-femoral intervention (TFI). However,
there have been limited data regarding clinical outcomes of TRI versus TFI in ST
elevation myocardial infarction (STEMI) patients (pts) in Asian population.
Methods: A total of 689 consecutive STEMI pts from nine major hospitals were
enrolled from Jan to Dec 2009. Cumulative major clinical outcomes up to 12 months
were compared between TRI (n¼220, 31.9%) and TFI group (n¼469, 28.1%).
Results: Baseline characteristics showed that TRI group had more smokers and a
higher incidence of hypertension, diabetes mellitus and previous cerebrovascular ac-
cidents whereas TFI group had a higher incidence of multi-vessel disease, left
circumﬂex lesion, type B2 or C lesion and chronic total occlusion. TRI group had a
lower incidence of major and minor hemorrhage during admission. Clinical outcomes
up to 12 months showed that the incidence of recurrent myocardial infarction, target
lesion revascularization (TLR) and target vessel revascularization (TVR) were lower
in the TRI group. Propensity score matched analysis showed that TRI was an inde-
pendent predictor of reducing TVR (OR: 0.08 95% CI: 0.01-0.67, p Value¼0.019),
MACE (OR: 0.37, 95% CI: 0.15-0.86, p Value¼0.022), and MACCE (OR: 0.33, 95%
CI: 0.14-0.76, p Value¼0.010) at 12 months.
Conclusion: In our study, TRI in STEMI pts undergoing primary PCI with DES was
associated with lower 12-months TVR, MACE and MACCE. We suggest that TRI
may play an important role in improving mid-term major clinical outcomes of STEMI
pts undergoing PCI with DESs.JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/POST
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Background: Transradial access (TRA) for percutaneous coronary intervention and
diagnostic coronary angiography has become an emerging trend in the routine practice
in most catheterization laboratory as it reduces the incidence of major access site
complications such as bleeding and haematoma. Radial artery spasm and perforation
are the main reasons for converting a procedure to femoral access. We prospectively
investigate the use of Sheathless EauCath (Asahi Intecc, Aichi, Japan) in cases of
radial artery spasm and perforation.
Methods: From Jan 2011 till Oct 2013, all patients with angiographically documented
radial artery spasm with or without perforation and failure of conventional 5 or 6 Fr
diagnostic or guiding catheters to cross the artery despite of repeated intra-arterial
nitroglycerin and/or verapamil were elected to attempt for Sheathless EauCath. The
procedural success, angiography of the forearm post procedure and access site out-
comes were evaluated.
Results: 36 patients, amean age of 619 yrswith 64%male, had signiﬁcant radial artery
spasm (n¼25, 69%) or perforation+spasm (n¼11, 31%) fulﬁlled the criteria for the use
of Sheathless EauCath. Procedural indications are stable angina in 18%, unstable angina
in 3%, non-ST elevation myocardial infarction (NSTEMI) in 54%, ST-elevation
myocardial infarction (STEMI) in 15% and 10% for other diagnostic procedures. 6.5 Fr
Sheathless EauCathwas used in 34 patients (94%) and 7.5 Frwas used in the remaining 2
patients (6%). The Sheathless EauCath was able to overcome the spasm with or without
perforation in all caseswith all patients achieved a successful procedural outcome.Of the
11 patients who had perforation of the radial artery, 10 patients (91%) had post-proce-
dural angiography showed no extravasation of contrast. The remaining one patient who
had trivial residual contrast extravasation outside the radial artery was successfully
managed with pressure dressing without signiﬁcant complications. There was no case of
haematoma or access site related bleeding issues.
Conclusion: The Sheathless EauCath can be used safely to overcome the radial artery
spasm and perforation during transradial coronary intervention or diagnostic procedures.
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Background: The latest EuropeanSociety ofCardiologyguidelines for themanagement
of acute myocardial infarction (AMI) in patients with ST-segment elevation recommend
transradial coronary intervention (TRI) to reduce the risk of vascular complications. We
evaluated the feasibility of TRI in patients with AMI complicated by cardiac arrest.
Methods: We retrospectively evaluated 20 consecutive patients with AMI who
required an extracorporeal membrane oxygenator (ECMO) because of cardiopulmo-
nary arrest resistant to conventional cardiopulmonary resuscitation. Percutaneous
access sites and evaluation criteria, including onset-to-ECMO time, door-to-balloon
time, and 30-day survival, were investigated.
Results: TRI was performed in 13 patients, whereas the other 7 patients underwent
transfemoral coronary intervention (TFI). No signiﬁcant differences in onset-to-
admission time (mean  SD: 26.8  14.6 vs. 17.0  13.3 min), onset-to-ECMO time
(41.8  18.8 vs. 39.0  16.6 min), and door-to-balloon time (61.4  19.1 vs. 79.3 ER/Transradial Intervention S35
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19th CardioVascular Summit: TCTAP 201421.0 min) were found between the TRI and TFI groups. The 30-day survival rate was
38% in all patients, 31% in the TRI group, and 43% in the TFI group.
Conclusion: The present study demonstrates that when performed by a skilled operator,
TRI is equally feasible as TFI for patients with AMI complicated by cardiac arrest.
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Background: Radial artery spasm (RAS) is one of themain reasons causing failure and/or
complication of trans-radial intervention (TRI). Causes of spasm include anxious/sensitive
patient, small radial artery size, frequent catheter passage especially guiding catheter with
relative blunt tip. RAS usually resolves with intra-arterial vasodilator, sedation and/or
analgesics but sometimes persists despite all kinds of treatment. Since brachial artery spasm
rarely occurs and initial entry of radial sheath with the assistance of the tapered dilator is
usually easy, use of long radial sheath up to distal brachial artery should avoid RAS.
Methods: The experience of using 6F 25cm long radial sheath (St Jude Engage TR
sheath) by a single operator at a single cardiac catheterization laboratory (CCL) from
mid June to October 2013 was reported.
Results: There was a total of 41 coronary procedures done by the author at that
CCL during that period. There were 33 coronary angiogram (CA) proceeding to
percutaneous coronary intervention (PCI), 5 CA with intravascular ultrasound but not
PCI, and 3 CA only. There were 30 males and 11 females, with average age of
62.7 years old and body weight of 67.6 kg. All CA or/and PCI were successfully done
trans-radially using the 6F 25cm long radial sheath except in two patients in whom a
6F 10cm Terumo radial sheath was used instead due to the course of the 0.025 inch
radial sheath guidewire was considered not entirely satisfactory. No switch over to
trans-femoral route was needed. No RAS was noted. No injection of vasodilator/
sedation/ analgesics was needed except for one patient who had mild spasm of distal
brachial artery after the 0.035 inch guidewire passing through the loop and straight-
ening the loop at that distal bradial artery. The spasm was promptly resolved with
intra-arterial 200ug nitroglycerin. At the end of the procedures, all the sheaths were
successfully removed without difﬁculty or complication. TR bands were used for
haemostasis. All patients were discharged the next morning. No major adverse cardiac
event or vascular complication was noted during hospitalization and clinic follow-up
within a week after procedure.
Conclusion: TRI using long radial sheath up to distal brachial artery eliminated RAS,
and appeared safe. A larger scale, prospective randomized trial of long versus ordinary
radial sheath in TRI may be warranted.
Valvular Heart Disease
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Background: The design and ﬂow proﬁle of transcatheter aortic valve (TAVI) is
different from surgical prosthetic valve. We compared the post implantation echo-
cardiographic aortic valve gradient of patients undergoing TAVI using Edwards Sa-
pien in our institution to that of surgically implanted bioprosthetic valves (SAVR)
using St Jude Epic, Hancock and Mitrﬂow valves during the same period.
Methods: Consecutive patients who underwent TAVI between January 2010 and May
2011 were included. Patients who underwent SAVR for native aortic stenosis (AS)
were identiﬁed from our database and patients who completed at least one follow up
transthoracic echocardiogram (TTE) were included for ﬁnal analysis. The last per-
formed TTE was included for analysis in both groups.
Results: Thirty six patients underwent TAVI valves between January 2010 and May
2011 and TTE data were available for 34 patients who were included for ﬁnal analysis.
Seventy two patients underwent SAVR with a bioprosthetic valve during the same
period and TTE data were available for 30 patients who were included for ﬁnal
analysis. Mean age (TAVI 83.4
Conclusion: Our initial results suggest excellent early haemodynamic performance of
Edwards Sapien TAVI valve compared to the commonly used surgical bio prosthetic
valves. TTE gradients were lower in the TAVI group than the surgical group but this
requires conﬁrmation in a large prospective patient series. Haemodynamically non-
signiﬁcant aortic regurgitation was signiﬁcantly more common in the TAVI group.
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Background: Rheumatic fever and subsequent Rheumatic heart disease is still widely
prevalent in many of Asian and African countries. Rheumatic heart disease causes
major morbidity and mortality in younger population in such highly prevalent areas.
Juvenile mitral stenosis in age group < 20 years varies uniquely from adult Rheumatic
heart disease. Juvenile mitral stenosis often present with morphologically more ﬁbrous
valve tissue, severe subvalvular disease and less incidence of valve calciﬁcation. Pul-
monary arterial hypertension is more common in this subgroup. Balloon Mitral val-
votomy in Juvenile mitral stenosis has its own limitation due to underlying unsuitable
anatomy of the mitral valve with more of subvalvular fusion and thus result in unsat-
isfactory outcomes. Moreover dedicated hardware for the size of this age group is not
widely available. In this study we analysed the safety and efﬁcacy of Balloon mitral
valvotomy in 329 patients of Juvenile mitral stenosis.
Methods: This retrospective study analysed 329 patients of Juvenile mitral stenosis who
underwent balloon mitral valvotomy in our centre from 1997 to 2011.The age group
ranged from 8 to 20 years with 162 males and 167 females. All patients underwent
detailed pre procedure echocardiographic assessment for suitability of balloon mitral
valvotomy. Left ventricular angiography in RAO view was used to compliment sub-
valvular disease assessment. Balloon mitral valvotomy was done by inoue technique.
Transeptal septal puncture was done with brokenborough needle assembly with ﬂuoro-
scopic guidance. Detailed echocardiofram was performed immediately after the balloon
dilatation . The safety of procedure is assessed by complication incurred during it. Known
complications of Balloon mitral valvotomy like pericardial effusion, cardiac tamponade,
Acute mitral regurgitation, arrhythmias and local vascular complications are noted.
The efﬁcacy of the procedure identiﬁed by achievement of mitral valve area > 1.5 cm2
without development of >grade 2 mitral regurgitation. Also > 50% reduction in mean
left atrial pressure was used as an additional surrogate marker of successful procedure.
Results: Out of 329 patients of Juvenile mitral stenosis 94.3% of patients technically
underwent the procedure completely. No sex predliction found in juvenile mitral
stenosis.3.6% of patients had failed transeptal puncture due to abnormal anatomy of
interatrial septum and 2.1% had subsequent failed left ventricular entry of balloon. For
commisurotomy Inoue balloon was used in 80.84% of cases, cribier commisurotome
device in 3.34% of cases and double balloon, Mansﬁeld balloon and combination in
fewer patients. Majority of patients had single balloon dilatation of stenotic mitral
valve, while 11% had serial balloon dilatations with upsizing, for unyielding valve
morphology.9.1% of patient developed acute mitral regurgitation and out of this 1.5%
had severe mitral regurgitation warranting emergency mitral valve replacement.
Pericardial effusion and Cardiac tamponade occurred in 2.4% of cases and was
managed accordingly. Simple arrthymias noted in 0.6% and local vascular compli-
cation was encountered in 1.2% of cases. one patient had cardiac arrest during pro-
cedure who was successfully resuscitated. No mortality was reported. Overall 7.5% of
cases had encountered procedure related complication.
Procedure was deﬁned successful in 65.95% of cases with good valve area and no
signiﬁcant mitral regurgitation and also without any complications. Signiﬁcant left
atrial pressure reduction was achieved in 65% of cases and < 50% reduction in
pressure was noticed in 16.7% of cases.4.86% of patients had very unyielding valve
despite serial balloon dilatation.
Conclusion: Balloon mitral valvotomy is still largely used as a deﬁnitive ther-
apy,palliative therapy and bridge to surgery in juvenile mitral stenosis.The Nature of
the disease and underlying anatomy of valve grossly determine the successful outcome
of the procedure in this subgroup. Balloon mitral valvotomy is deﬁnitely safe and
relatively efﬁcacious procedure in treating Juvenile mitral stenosis.April 22–25, 2014 j TCTAP Abstracts/ORAL/Valvular Heart Disease
